Citations Report
Citations Report - Drug Designing: Open Access [127 Articles]
The articles published in Drug Designing: Open Access have been cited 127 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.
Jian C, Zhang P, Ma J, Jian S, Zhang Q, Liu B, et al. The roles of fatty-acid modification in the activity of the anticancer peptide R-lycosin-I. Molecular pharmaceutics. 2018;15: 4612-20. |
|
Shoombuatong W, Schaduangrat N, Nantasenamat C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI journal. 2018;7: 734. |
|
Gelain A, Mori M, Meneghetti F, Villa S. Signal transducer and activator of transcription protein 3 (STAT3): An update on its direct inhibitors as promising anticancer agents. Current medicinal chemistry. 2019. |
|
Beebe JD, Liu JY, Zhang JT. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacology & therapeutics. 2018;191: 74-91. |
|
Chen X, Guo L, Ma Q, Chen W, Fan W, Zhang J. Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents. Molecules. 2019;24 :2950. |
|
Deokar H, Deokar M, Wang W, Zhang R, Buolamwini JK. QSAR studies of new pyrido [3, 4-b] indole derivatives as inhibitors of colon and pancreatic cancer cell proliferation. Medicinal Chemistry Research. 2018 ;27: 2466-81. |
|
Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. Journal of nanobiotechnology. 2019;17: 90. |
|
Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric. Radionanomedicine: Combined Nuclear and Nanomedicine. 2018: 105. |
|
Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019 : 118814. |
|
Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric Nanoparticles. InRadionanomedicine 2018. |
|
Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019;20: 118814. |
|
Satarupa M, Aruna V, Gayathri R. Villainous Effect of Sun and Goodness of Evefresh. Skin Diseases & Skin Care. 2017. |
|
Rao MS, Varma YN. Journal of Pharmaceutical and Scientific Innovation. |
|
Kwofie SK, Broni E, Teye J, Quansah E, Issah I, Wilson MD,et al. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24. Computers in biology and medicine. 2019;113: 103414. |
|
Armando R, Mengual Gómez D, Juritz E, Lorenzano Menna P, Gomez D. Homology model and docking-based virtual screening for ligands of human dyskerin as new inhibitors of telomerase for cancer treatment. International journal of molecular sciences. 2018;19: 3216. |
|
Kwofie S, Dankwa B, Odame E, Agamah F, Doe L, Teye J, et al. In silico screening of isocitrate lyase for novel anti-buruli ulcer natural products originating from Africa. Molecules |
|
Pastor-Anglada M, Pérez-Torras S. Who is who in adenosine transport. Frontiers in pharmacology. 2018;9. |
|
Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SA, Mani V, et al. In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC chemistry. 2019;13: 90. |
|
Kumar S, Sharma D, Narasimhan B, Ramasamy K, Shah SA, Lim SM, et al. Computational approaches: discovery of GTPase HRas as prospective drug target for 1, 3-diazine scaffolds. BMC chemistry. 2019;13: 96. |
|
Kakkar S, Kumar S, Lim SM, Ramasamy K, Mani V, Shah SA, et al. Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2 H-chromen-2-one derivatives. Chemistry Central Journal. 2018;12: 130. |
|